Paul Winyard is Emeritus Professor of Experimental Medicine at the University of Exeter Medical School, and a Co-founder/Director of the University spin-out company, Watercress Research Limited. Before moving his laboratory to Exeter in 2002, he was Professor of Experimental Medicine at Barts and the London School of Medicine and Dentistry, and a Visiting Professor at the University of California, San Francisco (2000-2001).

Professor Winyard's internationally leading research into the redox regulation of the inflammatory response is relevant to many different human diseases - spanning from rheumatoid arthritis to dermatitis, and from cardiovascular disease to Alzheimer's disease. He has published well over 300 original research papers and reviews, many of which are highly cited in the literature. Over the last decade, he has developed a particular interest in human skin-related anti-inflammatory and antimicrobial effects of phytochemicals in watercress.

Professor Winyard’s laboratory-based research group has been supported by the UK government's research funding agencies such as the MRC, BBSRC, EPSRC and MoD, as well as the European Union’s research funding programmes. Medical research charity funding has kindly been provided by the Torbay Medical Research Trust, Versus Arthritis, Devon Arthritis and Allied Research Trust, the Northcott Devon Medical Foundation and others.

He is an Inventor in relation to more than a dozen University-owned Patents, including a “process, composition and uses” Patent, in relation to novel extracts from watercress. The latter Patent has recently been licensed from the University by his company, Watercress Research Limited.